CAS 637301-29-2

4-[2-[[(1S)-1-(2-aminophenyl)-3-methyl-butyl]amino]-2-oxo-ethyl]-2-ethoxy-benzoic acid

Description:

4-[2-[[(1S)-1-(2-aminophenyl)-3-methyl-butyl]amino]-2-oxo-ethyl]-2-ethoxy-benzoic acid, with CAS number 637301-29-2, is a complex organic compound characterized by its multi-functional structure. It features a benzoic acid moiety, which contributes to its acidic properties, and an ethoxy group that enhances its solubility in organic solvents. The presence of an amino group indicates potential for hydrogen bonding and reactivity, making it a candidate for various biological interactions. The compound's stereochemistry, indicated by the (1S) configuration, suggests specific spatial arrangements that may influence its biological activity and pharmacokinetics. Additionally, the presence of a bulky 3-methyl-butyl group may affect its lipophilicity and overall molecular interactions. This compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals, due to its potential biological activity stemming from its unique structural features. However, detailed studies would be necessary to fully elucidate its properties and applications.

Formula: C₂₂H₂₈N₂O₄

InChI: InChI=1/C22H28N2O4/c1-4-28-20-12-15(9-10-17(20)22(26)27)13-21(25)24-19(11-14(2)3)16-7-5-6-8-18(16)23/h5-10,12,14,19H,4,11,13,23H2,1-3H3,(H,24,25)(H,26,27)/t19-/m0/s1

SMILES: CCOc1cc(ccc1C(=O)O)CC(=N[C@@H](CC(C)C)c1ccccc1N)O

Repaglinide Impurity 12

CAS: 637301-29-2

Formula: C₂₂H₂₈N₂O₄

Molecular weight: 384.48

Ref: 4Z-R-1134

4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic Acid

Controlled Product

CAS: 637301-29-2

Formula: C₂₂H₂₈N₂O₄

Color and Shape: Neat

Molecular weight: 384.469

Ref: TR-S292410

Repaglinide Impurity 12

CAS: 637301-29-2

Formula: C₂₂H₂₈N₂O₄

Molecular weight: 384.48

Ref: ST-EA-CP-R24023

4-[2-[[(1S)-1-(2-Aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic acid

CAS: 637301-29-2

Bosentan is a potent inhibitor of the uptake of organic anions. It is used in the treatment of pulmonary arterial hypertension and has been shown to be effective against pravastatin-resistant HIV protease inhibitors, such as saquinavir, quinidine, and rosuvastatin. Bosentan inhibits uptake by binding to the transporter protein at a site that does not overlap with the binding site for organic anion substrates. This leads to a change in kinetic parameters for substrates, such as pravastatin and saquinavir. The binding site on bosentan may also be elucidated through monolayer experiments with efflux transporters.

Formula: C₂₂H₂₈N₂O₄

Purity: Min. 95%

Molecular weight: 384.47 g/mol

Ref: 3D-FD21379